{
  "id": "nclex_ngn_vf_safetystop_002",
  "questionType": "selectN",
  "cjmmModel": {
    "layer": 3,
    "step": "Take Actions"
  },
  "stem": "The nurse is caring for a 68-year-old client in the emergency department who achieved Return of Spontaneous Circulation (ROSC) 40 minutes ago after a cardiac arrest due to ventricular fibrillation. The nurse is reviewing the client's electronic health record (EHR) and the most recent provider orders. Which actions should the nurse implement immediately? Select all that apply.",
  "ehrTabs": [
    {
      "tabName": "Nurses' Notes",
      "content": "<b>0800:</b> Client arrived via EMS after a witnessed collapse at home. Bystander CPR was in progress. EMS reports initial rhythm was ventricular fibrillation, defibrillated x1 with subsequent ROSC. Client was intubated in the field. History per family: Hypertension, Type 2 Diabetes, Stage 3 Chronic Kidney Disease (CKD). Family reports client has been non-adherent with medications recently, stating they 'could not afford the refills this month.'\n\n<b>0835:</b> Client becoming increasingly agitated, attempting to pull at endotracheal tube and bucking the ventilator. Sedation appears inadequate. Provider at bedside notified of change in status and new laboratory results."
    },
    {
      "tabName": "Vital Signs",
      "content": [
        {
          "time": "0800",
          "BP": "110/70 mmHg",
          "HR": "105 bpm",
          "RR": "16/min (Ventilator)",
          "SpO2": "96%",
          "Temp": "36.5째C"
        },
        {
          "time": "0815",
          "BP": "102/65 mmHg",
          "HR": "112 bpm",
          "RR": "16/min (Ventilator)",
          "SpO2": "94%",
          "Temp": "36.5째C"
        },
        {
          "time": "0830",
          "BP": "88/50 mmHg",
          "HR": "125 bpm",
          "RR": "16/min (Ventilator)",
          "SpO2": "92%",
          "Temp": "36.4째C"
        }
      ]
    },
    {
      "tabName": "Laboratory Results",
      "content": "<b>Time Drawn: 0810 | Status: Final</b>\n- Potassium: <b>6.8 mEq/L</b> (Reference: 3.5-5.0 mEq/L)\n- Sodium: 138 mEq/L (Reference: 136-145 mEq/L)\n- BUN: 55 mg/dL (Reference: 10-20 mg/dL)\n- Creatinine: 2.9 mg/dL (Reference: 0.6-1.2 mg/dL)\n- Lactate, Venous: 5.2 mmol/L (Reference: 0.5-2.2 mmol/L)\n- Troponin I: 0.8 ng/mL (Reference: <0.04 ng/mL)\n- ABG (on FiO2 100%): pH 7.20, PaCO2 50 mmHg, PaO2 85 mmHg, HCO3 18 mEq/L"
    },
    {
      "tabName": "Diagnostics",
      "content": "<b>Post-ROSC 12-Lead ECG Interpretation (0805):</b>\nSinus tachycardia with rate of 110. Widened QRS complex (0.14 seconds). Prominent, peaked T waves noted in precordial leads. No acute ST-segment elevation.\n\n<b>Portable Chest X-Ray (0820):</b>\nEndotracheal tube tip is 3 cm superior to the carina. Mild diffuse pulmonary edema."
    },
    {
      "tabName": "Provider Orders",
      "content": "<b>Time: 0840</b>\n1. Succinylcholine 1.5 mg/kg IV push NOW for ventilator asynchrony.\n2. Start Norepinephrine infusion at 5 mcg/min, titrate to maintain Mean Arterial Pressure (MAP) > 65 mmHg.\n3. Administer Sodium Bicarbonate 1 ampule (50 mEq) IV push NOW.\n4. Administer Amiodarone 150 mg IV infusion over 10 minutes.\n5. Prepare for initiation of targeted temperature management protocol."
    }
  ],
  "options": [
    {
      "label": "C",
      "content": "Initiate the norepinephrine infusion."
    },
    {
      "label": "A",
      "content": "Administer the prescribed succinylcholine to improve oxygenation."
    },
    {
      "label": "B",
      "content": "Withhold the succinylcholine and question the order with the provider."
    },
    {
      "label": "D",
      "content": "Administer the sodium bicarbonate IV push."
    },
    {
      "label": "E",
      "content": "Prepare equipment for targeted temperature management."
    },
    {
      "label": "F",
      "content": "Administer the amiodarone infusion over 10 minutes."
    }
  ],
  "correctAnswer": [
    "B",
    "C",
    "D"
  ],
  "rationale": {
    "correct": "The client is exhibiting signs of post-cardiac arrest syndrome, including hypotension, metabolic acidosis, and hyperkalemia. The priority is to address the life-threatening hyperkalemia and support blood pressure. Succinylcholine is contraindicated due to the risk of further increasing potassium levels. Norepinephrine will increase blood pressure and improve organ perfusion. Sodium bicarbonate will help correct the metabolic acidosis and temporarily shift potassium intracellularly.",
    "incorrect": "Incorrect actions either pose a direct and immediate threat to the client's life or fail to address the highest priority problems of severe hyperkalemia and distributive shock. Choosing the incorrect options demonstrates a failure to recognize a critical contraindication or prioritize interventions based on the most life-threatening data points.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Administer the prescribed succinylcholine to improve oxygenation.",
        "isCorrect": false,
        "justification": "Incorrect. Succinylcholine is a depolarizing neuromuscular blocker that can cause a transient increase in serum potassium. In a client with hyperkalemia (6.8 mEq/L), this could induce a fatal arrhythmia. The pathophysiology involves succinylcholine binding to acetylcholine receptors, causing depolarization and efflux of potassium from muscle cells. This is especially dangerous in patients with CKD, who already have impaired potassium excretion. Clinical Pearl: Always check potassium levels before administering succinylcholine, especially in patients with renal dysfunction or a history of hyperkalemia."
      },
      {
        "label": "B",
        "content": "Withhold the succinylcholine and question the order with the provider.",
        "isCorrect": true,
        "justification": "Correct. The client's potassium level of 6.8 mEq/L is critically high. Succinylcholine can cause a further increase in serum potassium, potentially leading to life-threatening arrhythmias such as ventricular fibrillation or asystole. The nurse's role as a patient advocate requires questioning orders that could harm the patient. The pathophysiology behind this contraindication lies in succinylcholine's mechanism of action, which causes potassium efflux from muscle cells. Clinical Pearl: Hyperkalemia is an absolute contraindication for succinylcholine administration. Always prioritize patient safety by questioning potentially harmful orders. "
      },
      {
        "label": "C",
        "content": "Initiate the norepinephrine infusion.",
        "isCorrect": true,
        "justification": "Correct. The client's blood pressure is trending downward (110/70 to 88/50), indicating shock. Norepinephrine is a vasopressor that increases blood pressure by stimulating alpha-adrenergic receptors, causing vasoconstriction. The high lactate level (5.2 mmol/L) suggests tissue hypoperfusion, further supporting the need for vasopressor support. The pathophysiology involves the body's compensatory mechanisms failing to maintain adequate perfusion after cardiac arrest, leading to anaerobic metabolism and lactic acid production. Clinical Pearl: Early initiation of vasopressors is crucial in post-ROSC care to maintain adequate organ perfusion and prevent secondary ischemic injury. Aim for a MAP > 65 mmHg."
      },
      {
        "label": "D",
        "content": "Administer the sodium bicarbonate IV push.",
        "isCorrect": true,
        "justification": "Correct. The client's arterial blood gas (ABG) shows a pH of 7.20 and HCO3 of 18 mEq/L, indicating metabolic acidosis. Sodium bicarbonate helps to buffer the excess acid in the bloodstream, raising the pH. Additionally, sodium bicarbonate can temporarily shift potassium intracellularly, helping to stabilize the cardiac membrane in the setting of hyperkalemia. The pathophysiology involves the accumulation of lactic acid and other acidic metabolites due to tissue hypoperfusion and impaired cellular metabolism post-arrest. Clinical Pearl: Sodium bicarbonate is indicated in severe metabolic acidosis (pH < 7.2) and hyperkalemia with ECG changes. Monitor ABGs closely to assess the response to treatment."
      },
      {
        "label": "E",
        "content": "Prepare equipment for targeted temperature management.",
        "isCorrect": false,
        "justification": "Incorrect. While targeted temperature management (TTM) is a standard of care for comatose survivors of out-of-hospital cardiac arrest, it is not the most immediate priority. Stabilizing the client's hemodynamics (shock) and correcting life-threatening electrolyte disturbances (hyperkalemia) must occur first. TTM can be initiated once the client is stabilized. The pathophysiology behind TTM involves reducing cerebral metabolic rate and preventing secondary brain injury by mitigating the effects of ischemia and reperfusion. Clinical Pearl: Initiate TTM after addressing immediate life threats such as shock and electrolyte imbalances. The goal is to maintain a target temperature of 32-36째C for 24 hours."
      },
      {
        "label": "F",
        "content": "Administer the amiodarone infusion over 10 minutes.",
        "isCorrect": false,
        "justification": "Incorrect. Although amiodarone is an antiarrhythmic medication, the client's current ECG changes (peaked T waves, wide QRS) are characteristic of severe hyperkalemia, not a primary arrhythmia that amiodarone would correct. The immediate priorities are treating the underlying causes: shock and hyperkalemia. Administering amiodarone does not address these root problems and delays life-saving interventions. The pathophysiology involves the disruption of normal cardiac conduction due to electrolyte imbalances, leading to abnormal ECG findings. Clinical Pearl: Always identify and treat the underlying cause of arrhythmias. In this case, hyperkalemia is the primary driver of the ECG changes, not an intrinsic arrhythmia requiring amiodarone."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Evaluating",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Management of Care",
    "nclexSubcategory": "Establishing Priorities",
    "difficulty": "Level 5 - Highly Discriminating",
    "topicTags": [
      "Ventricular Fibrillation",
      "Post-ROSC Care",
      "Hyperkalemia",
      "Medication Safety",
      "Contraindication",
      "Shock Management",
      "Acid-Base Imbalance"
    ]
  },
  "clinicalPearls": [
    "Succinylcholine is contraindicated in patients with hyperkalemia due to the risk of further increasing serum potassium levels and precipitating life-threatening arrhythmias.",
    "Post-ROSC care focuses on addressing the underlying causes of the arrest, optimizing hemodynamics, and preventing secondary brain injury.",
    "Peaked T waves and widened QRS complexes on an ECG in the setting of hyperkalemia warrant immediate intervention to stabilize the cardiac membrane and shift potassium intracellularly."
  ],
  "sentinelStatus": "healed_v2026_v8",
  "sbar": {
    "situation": "The client is a 68-year-old male who achieved ROSC after cardiac arrest due to ventricular fibrillation approximately 40 minutes ago. He has a history of hypertension, type 2 diabetes, and stage 3 CKD.",
    "background": "The client was found collapsed at home with bystander CPR in progress. EMS reported initial rhythm was ventricular fibrillation, defibrillated x1 with subsequent ROSC. He was intubated in the field. Family reports medication non-adherence due to cost.",
    "assessment": "The client is increasingly agitated and bucking the ventilator. Vital signs show worsening hypotension (BP 88/50), tachycardia (HR 125), and desaturation (SpO2 92%). Labs reveal hyperkalemia (K+ 6.8), metabolic acidosis (pH 7.20, HCO3 18), elevated lactate (5.2), and elevated BUN/Creatinine. ECG shows peaked T waves and widened QRS.",
    "recommendation": "Withhold the succinylcholine order due to hyperkalemia. Initiate norepinephrine infusion to maintain MAP > 65 mmHg. Administer sodium bicarbonate IV push to address acidosis and hyperkalemia. Prepare for targeted temperature management after stabilizing hemodynamics and electrolyte imbalances."
  }
}